Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EIA (An enzyme immunoassay) useful in detecting enteroviral meningitis:

This article was originally published in Clinica

Executive Summary

An enzyme immunoassay (EIA) for anti-enterovirus IgM antibodies in serum is a valuable tool in the diagnosis of enteroviral meningitis, a German team has reported in the Journal of Medical Virology (June). In a study of 43 patients with enterovirus meningitis confirmed by reverse transcription PCR, Dr Gisela Enders and colleagues at the Stuttgart Institut fur Virologie, Infektiologie und Epidemiologie found that the EIA was able to correctly identify the antibodies in 34% of the cases, compared with only 20% found by a complement fixation test. The EIA also identified three out of four meningitis patients in whom the virus was not detectable in cerebrospinal fluid samples.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT076336

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel